Market Currents
Smaller medical-device makers such as Cardica (CRDC) are tacking surcharges on to their products...
-
Sunday, January 27, 3:30 AM ETSmaller medical-device makers such as Cardica (CRDC) are tacking surcharges on to their products or warning of price increases to cover a 2.3% sales tax that came into force on Jan. 1 as part of Obamacare. Larger manufacturers like Medtronic (MDT) and GE Healthcare (GE) haven't explicitly added extra fees but are expected to bake them into contract renewals.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 13 comments:
Let the facts fall where they may. President Obama hates business's.
http://apne.ws/WgrsYF
I would think that if you want a medical device and the price goes up by 2.3% for all of the makers, then you just have to suck it up and pay the higher price. (E.g. you can't switch from, say, Boston Scientific to Medtronic for a lower cost device since the 2.3% is added to all transactions no matter what.)
These 2.3% is not applied on Profits, they are applied on your Revenues. For example you are selling a product for $100, and used to make $7 out of it. Now you have to pay 2.3% which is 2.3$ out of your revenue. So, you are left with $4.7 profit. This means you have just lost 33% of your profit. (not 2.3%).
For a lot of start-ups and innovative smaller companies, they will be happy to even get a 5% profit, so now 50% of their profits will be gone, unless they pass them directly to the customers.
This tax is not that painful for the already profitable companies, but extremely painful for the innovative smaller companies.